Bruce Donald's company featured at Duke Venture Day

Gavilan Biodesign Company Logo
GCB News

Bruce Donald's company featured at Duke Venture Day

Bruce Donald’s company, Gavilán Biodesign, was featured as one of eight Duke start-up investments at the first Duke Venture Day earlier this month. This event showcased therapeutic innovations currently coming out of Duke. Gavilan Biodesign was recently selected as one of 11 early-stage biotech companies at the Silicon Valley biotech accelerator, IndieBio. Their technology combines state of the art physics-based modeling with a unique high accuracy AI platform to computationally screen trillions of molecules in order to find therapeutics that can overcome resistance. 

Story adopted from an article originally posted on the Office of Licensing and Ventures on May 9, 2019.

Related News

stack of books

Research Roundup: June 2020

Here are summaries of a selection of the papers published by GCB faculty in June 2020:

Fluorescently labeled E. coli growing in droplets from h 0 to h 9. We facilitated imaging by overloading E. coli (i.e., most droplets were initially loaded with more than one E. coli cell).

Wait for it…MicDrop

New platform quickly analyzes bacterial strains in the microbiome

By Alissa Kocer

GCB: Genomic and computation biology

GCB to transition to center within Biostatistics and Bioinformatics

After six successful years as a member of Duke University Institiutes and Centers, GCB is finding a new home in the Department of Biostat